Literature DB >> 571837

The transsphenoidal surgical approach to the pituitary.

J Hardy.   

Abstract

The operating microscope and intraoperative fluoroscopic monitoring have converted this approach from a blind procedure into a precise operation that permits selective (as well as nonselective) resection of pituitary tumors, often restoring function to normal or near-normal levels. Experience with the technique has also shed new light on the pathophysiology of acromegaly, Cushing's disease, and hyperprolactinemia.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 571837     DOI: 10.1080/21548331.1979.11707562

Source DB:  PubMed          Journal:  Hosp Pract        ISSN: 0018-5809


  12 in total

Review 1.  Surgery for acromegaly: evolution of the techniques and outcomes.

Authors:  Edward R Laws
Journal:  Rev Endocr Metab Disord       Date:  2008-03       Impact factor: 6.514

2.  Cerebrospinal fluid leaks in extended endoscopic transsphenoidal surgery: covering all the angles.

Authors:  Hussein Fathalla; Antonio Di Ieva; John Lee; Jennifer Anderson; Rowan Jing; Michael Solarski; Michael D Cusimano
Journal:  Neurosurg Rev       Date:  2016-08-24       Impact factor: 3.042

3.  Perioperative complications of transseptosphenoidal excision for pituitary adenomas.

Authors:  M S Persky; E Brunner; P R Cooper; N L Cohen
Journal:  Skull Base Surg       Date:  1996

4.  Long-Term Outcomes of Pituitary Gland Preservation in Pituitary Macroadenoma Apoplexy: Case Series and Review of the Literature.

Authors:  John Robert Souter; Ignacio Jusue-Torres; Kurt Grahnke; Ewa Borys; Chirag Patel; Anand V Germanwala
Journal:  J Neurol Surg B Skull Base       Date:  2019-11-11

5.  Sphenoid sinus pneumatization: the good, the bad, and the beautiful.

Authors:  K Badran; A Tarifi; A Shatarat; D Badran
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-03-04       Impact factor: 3.236

6.  Progressive improvement of impaired visual acuity during the first year after transsphenoidal surgery for non-functioning pituitary macroadenoma.

Authors:  O M Dekkers; R J W de Keizer; F Roelfsema; A A Vd Klaauw; P J Honkoop; H van Dulken; J W A Smit; J A Romijn; A M Pereira
Journal:  Pituitary       Date:  2007       Impact factor: 4.107

7.  High prevalence of metabolic syndrome features in patients previously treated for nonfunctioning pituitary macroadenoma.

Authors:  Sjoerd D Joustra; Kim M J A Claessen; Olaf M Dekkers; André P van Beek; Bruce H R Wolffenbuttel; Alberto M Pereira; Nienke R Biermasz
Journal:  PLoS One       Date:  2014-03-07       Impact factor: 3.240

8.  5-ALA Fluorescence in Native Pituitary Adenoma Cell Lines: Resection Control and Basis for Photodynamic Therapy (PDT)?

Authors:  Andrei Nemes; Thomas Fortmann; Stephan Poeschke; Burkhard Greve; Daniel Prevedello; Antonio Santacroce; Walter Stummer; Volker Senner; Christian Ewelt
Journal:  PLoS One       Date:  2016-09-01       Impact factor: 3.240

9.  Decrease in scale invariance of activity fluctuations with aging and in patients with suprasellar tumors.

Authors:  S D Joustra; C Gu; J H T Rohling; L Pickering; M Klose; K Hu; F A Scheer; U Feldt-Rasmussen; P J Jennum; A M Pereira; N R Biermasz; J H Meijer
Journal:  Chronobiol Int       Date:  2017-11-28       Impact factor: 2.877

10.  Transcriptome analysis of MENX-associated rat pituitary adenomas identifies novel molecular mechanisms involved in the pathogenesis of human pituitary gonadotroph adenomas.

Authors:  Misu Lee; Ilaria Marinoni; Martin Irmler; Tsambika Psaras; Jürgen B Honegger; Rudi Beschorner; Natasa Anastasov; Johannes Beckers; Marily Theodoropoulou; Federico Roncaroli; Natalia S Pellegata
Journal:  Acta Neuropathol       Date:  2013-06-12       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.